| Literature DB >> 24601903 |
L Daniel Maxim1, Ron Niebo, Ernest E McConnell.
Abstract
Perlite is a generic name for an amorphous volcanic alumina-silicate rock that expands by a factor of 4-20 when rapidly heated to 1400-1800 °F (760-980 °C). Both the ore and the expanded product have extensive and widespread commercial applications. Limited data on the toxicology of perlite in animal studies indicate that the LD₅₀ (oral ingestion) is more than 10 g/kg and, from a chronic inhalation study in guinea pigs and rats, that the NOAEL for the inhalation pathway is 226 mg/m³. Health surveillance studies of workers in US perlite mines and expansion plants (including some workers exposed to levels greater than prevailing occupational exposure limits (OELs) conducted over 20 years indicate that the respiratory health of workers is not adversely affected. Studies in Turkish mines and expanding plants had generally similar results, but are more difficult to interpret because of high smoking rates in these populations. A recent mortality study of permanent residents of the island of Milos (Greece) exposed to various mining dusts (including perlite) resulted in non-significant increases in standard mortality ratios for pneumonia and chronic obstructive pulmonary disease (COPD), whereas a companion morbidity study revealed elevated odds ratios for allergic rhinitis, pneumonia, and COPD when compared to another industrial area of Greece. Residents were exposed to other mining dusts and other possible causes or contributing factors and no ambient monitoring data were presented so it is not possible to use this study for risk calculations of perlite-exposed populations. Perlite is regulated as a "nuisance dust" in most countries.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24601903 PMCID: PMC4002636 DOI: 10.3109/08958378.2014.881940
Source DB: PubMed Journal: Inhal Toxicol ISSN: 0895-8378 Impact factor: 2.724
Figure 1.Ten largest perlite producers in 2011 ranked in descending order of output (% of world production). These accounted for 95% of world production of perlite (3 470 000 metric) Source: British Geological Survey, 2013.
Chemical composition of Perlite from various sources.
| Origin | US | Greece | Turkey | Hungary | Yemen | Korea | Bulgaria | Slovakia |
|---|---|---|---|---|---|---|---|---|
| SiO2 | 65–77.5 | 71–75 | 71–75 | 68–75 | 65–75 | 68–69 | 70–80 | 68–73 |
| Al2O3 | 11–18 | 12–16 | 12.5–18 | 10–15 | 9.4–12.8 | 11.95–15.8 | 10–15 | 7.5–15 |
| Na2O | 2.4–4.6 | 3.0–4.0 | 2.9–4.0 | 2.8–4.5 | 3.37–4.25 | 3.2–4.4 | <10 | 2.5–5.0 |
| K2O | 1.4–5.7 | 4.0–5.0 | 4.0–5.0 | 3.2–4.5 | 3.6–4.1 | 2–3.94 | <10 | 2–5.5 |
| Fe2O3 | 0.5–2.2 | 0.5–2.0 | 0.1–1.5 | 1.0–2.5 | 2.68–3.66 | 0.7–1.63 | <1.5 | 1.0–2.0 |
| MgO | 0.1–0.7 | 0.2–0.7 | 0.03–0.5 | 0.2–1.5 | 0.5–0.93 | 0.35–0.48 | <1.0 | <1.0 |
| CaO | 0.5–3.6 | 0.5–1.5 | 0.5–2.0 | 1.5–2.0 | 0.87–1.84 | 1.57–1.89 | <1.5 | 0.5–2.0 |
| Loss on ignition | 2–5 | 2–5 | 4.1 | 2.0–5.0 | 0.35–3.94 | NR | <5 | 3.0–4.1 |
| Source | Diverse | Sampatakakis et al., | Doğan & Alkan, | Mineralholding Ltd. | Sa’ad et al., | Noh & Boles, | Yanevaet al., | LB Minerals |
Mineralholding Ltd. Data available at http://www.mineralholding.hu/ipariasvanyok/en/raw_perlite.html.
Data for US taken from various mines, mineral deposit reports, and technical data sheets. Illustrative sources include Coombs, 1952; Ennis, 2011; USEPA, 1995b; Huntting, 1949; Jaster, 1956; Rotella & Simandl, 1995; and Simandi et al., 1995. Endpoints of ranges may come from different deposits. Ore from all countries may contain additional minor components (e.g. TiO2).
Summary information on perlite.
| Item | |
|---|---|
| CAS/EINECS NO. | CAS: 130885-09-5 (perlite ore); EINECS: Not listed CAS: 093763-70-3 (expanded perlite);EINECS: Not listed; RTECS No. SD5254000; REACH Exempted according to art.2 par 7b and Annex V.7. |
| NAICS (2012) Codes | Mining: 212399 (All other non-metallic mineral mines) Processing: 327992 (Ground or treated mineral and earth manufacturing) |
| Composition | Varies with source, see |
| Carcinogenicity | Not listed as a carcinogen by IARC, NTP, OSHA, or CA Prop 65. ACGIH: A4 – Not Classifiable as a Human Carcinogen Perlite does not meet the criteria for classification as hazardous according to EC Regulation 1272/2008 and Directive 67/548/EC as amended. |
| WHMIS | Does not meet criteria |
| FDA | GRAS SCOGS Report #61, 1979 ( |
| EFSA | EFSA approved in subcategory of binders, anticaking agents, and coagulants E 599 Panel on Additives and Products ( |
| OELs for selected countries | OSHA PNOR: 15 mg/m3 (total dust), 5 mg/m3 (respirable fraction) 8-h TWA NIOSH REL: 10 mg/m3 (total dust), 5 mg/m3 (respirable fraction) 8-h TWA ACGIH TLV: PNOS 10 mg/m3 (inhalable particles), 3 mg/m3 (respirable fraction) 8-h TWA Australia: 10 mg/m3, 8-h TWA Belgium: 10 mg/m3 (inhalable particles), 2 mg/m3 (respirable fraction) 8-h TWA Canada (Ontario, British Columbia): 10 mg/m3, 8-h TWA, |
| Potentially exposed cohort in the US | Total from NOES survey 215,854 persons in 1981–1983, see |
| Production (US) | Domestic production 424 000 metric tons; apparent consumption 557 000 metric tons (Bolen, |
| Major producing locations in US | The processed crude perlite was mined in eight mines located in Arizona, Idaho, Nevada, New Mexico, and Oregon (Bolen, |
See http://consultation.hsa.ie/general-applications/Chemical-Agents-Regulations-2011/public%20consultation%20draft%202011chemical%20agents%20COP%20January%202011.pdf.
See http://www.insht.es/InshtWeb/Contenidos/Documentacion/TextosOnline/Valores_Limite/GT-LEPN024-07%20VLA%202008%20negro_2.pdf.
Figure 2.Estimated SMRs and 95% confidence intervals by cause of death for men and women of Milos, Greece, combined for the period 1999–2009. Source: Data presented in Sampatakakis et al., 2013.
A summary of animal studies conducted with perlite.
| Pathway | Species | Results | Source |
|---|---|---|---|
| Inhalation | Guinea pig & rat | In an 18-month inhalation study, guinea pigs and rats (numbers, strain, or sex not given) were exposed to perlite dust at a concentration of 226 mg/m3. No significant pulmonary reaction, including fibrosis, was observed. No further details were given. The authors concluded that perlite acted as an inert or nuisance dust. | Vorwald, |
| Inhalation | Guinea pig | Inhalation exposure of 284 mg/m3, 8 h/d, 5.5 d/wk. for six months “appeared to stimulate the progression of experimental tuberculosis”. When exposure ceased the tuberculosis infection progressed for about eight months and then began to heal and ultimately was arrested. | Schepers, |
| Inhalation | Guinea pig | Guinea pigs were exposed to perlite dust at mean airborne concentrations of 0 or 6.6 mg/ml for 30 min/d, 5 d/wk, for 24 wk. Another group was exposed to fir bark dust. Perlite mass median aerodynamic diameters (MMADs) ranged from 1.7 to 1.9 µm. No pulmonary fibrosis or extensive destruction of parenchymal tissues was observed, but the authors con noted “moderate to severe” changes in the lungs for both dusts. The authors concluded that perlite particles were more than just a nuisance dust. | McMichael et al., |
| Intratracheal injection | Guinea pig | Nine perlite products were tested in guinea pigs, by weekly intratracheal injection of 0.5 ml of a 5% perlite suspension in saline for 3 wk. At 4 to 12 months after the last injection, no evidence of pulmonary fibrosis was shown. | Vorwald, |
| Intratracheal instillation | Rat | A single intratracheal instillation of a 75 mg/ml saline dose of perlite (18–30% quartz) produced a “foreign body reaction” in white male rats, but no pulmonary fibrosis was observed (post observation period not reported). | Timar et al., |
| Intratracheal instillation | Rat | A single 50 mg suspension of crude or expanded was administered intratracheally to albino rats. Nine months later, it was found that expanded perlite caused more lung fibrosis than crude perlite, but the degree of fibrosis was not reported. | Borshchevkii et al., |
| Intratracheal instillation | Rat | Rats given a single intratracheal instillation of 50 mg perlite dust showed pulmonary fibrosis at 12 to 18 months following administration. The perlite composition was not specified. | Liu et al., |
| Intratracheal instillation | Rat | Intratracheal infusing (instillation) of 5 mg perlite dust in 5% alcohol did not result in a strong pulmonary fibrogenic reaction in rats, at 12 wk after administration. No more details were provided. | Ueda et al., |
| Acute oral toxicity | Rat | Acute oral toxicity tests in rats ingesting perlite were performed by the Rosner-Hixon Laboratories in 1977. The results of the tests showed that the acute oral LD50 of perlites for rats is greater than the largest dose administered in the test (10 g/kg body weight). | Schundler Company, |
| Acute oral toxicity | Rat | In 1982, the WIL Research Laboratories conducted studies to examine the acute oral toxicity, if any, of agglomerated filter aid in albino rats. The study showed no signs of systemic toxicity, and concluded that the LD50 was greater than the highest dose level administered to the rats (10 g/kg body weight.) | Schundler Company, |
| Oral ingestion | Mouse | Ohkuma et al. ( | Cited in Sakai & Nagao, |
| Oral ingestion | Mouse | Groups of male and female mice were given diets containing 0%, 1%, 10%, 20% perlite for 28 wk. Appearance, behavior, and food consumption of mice of treated groups were not affected during the experimental period. | Sakai & Nagao, |